The factsheet discloses GlaxoSmithKline Pharmaceuticals as an unhedged holding at 3.94% of NAV.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Mirae Asset Sharekhan
Tata Asset Management
India IPO
Jainam
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Formerly known as Way2Wealth
Religare
Arete Securities
ICICI Direct
Way2Wealth Securities
ICICI Securities
quant Mutual Fund
Kotak Securities
JM Financial
ICICI Securities – Retail
Ventura Securities
Global Markets by Vested
Prabhudas Lilladher
ITC Hotels
Elara Securities
Exterminators PLC
Emkay Global
Industrial Asphalts
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
2620 notes · all time
The factsheet discloses Piramal Finance as an unhedged holding at 3.97% of NAV.
Read this note →The factsheet discloses LG Electronics India as an unhedged holding at 4.14% of NAV.
Read this note →The factsheet discloses Zydus Lifesciences as an unhedged holding at 4.34% of NAV.
Read this note →The factsheet discloses NSE of India as an unhedged holding at 4.89% of NAV.
Read this note →The factsheet discloses Gujarat Themis Biosyn as an unhedged holding at 5.24% of NAV.
Read this note →The factsheet discloses Laurus Labs as the second-largest unhedged position of the Equity Ex-Top 100 fund at 7.11% of NAV.
Read this note →The factsheet lists Indus Towers as the largest unhedged position of the qsif Equity Ex-Top 100 Long-Short Fund at 9.21% of NAV as on 30 September 2026.
Read this note →The note says its Rs 37,700 crore IPO approval was the week's largest regulatory development.
Read this note →The report says it received SME IPO approval for 41 lakh shares.
Read this note →The note says it received SME IPO approval for 92.25 lakh shares.
Read this note →The report says it received mainboard approval via the confidential route.
Read this note →The note says it received approval for an IPO of 74.45 lakh shares.
Read this note →The report says it filed an SME DRHP of 51.96 lakh shares.
Read this note →The note says it filed an SME DRHP of 35.36 lakh shares.
Read this note →The report says it filed the week's largest DRHP at Rs 3,750 crore, adding to the renewable-energy pipeline.
Read this note →The note says it filed for a proposed Rs 800 crore fresh issue plus an Offer for Sale.
Read this note →The report says it filed draft papers for an IPO of 1.60 crore shares.
Read this note →The note records a Rs 175.06 crore issue in civil construction.
Read this note →The report says it entered the market with a Rs 582.80 crore logistics issue.
Read this note →The note says it launched a Rs 700 crore issue in cables and electricals and has 35+ years of operating vintage.
Read this note →The report states it launched a Rs 720 crore mainboard issue.
Read this note →The note says it launched the week's largest IPO at Rs 1,757 crore in the pharmaceutical sector.
Read this note →The report says it was the week's weakest performer with a listing discount of 20%.
Read this note →The note records a 0.72% decline on listing.
Read this note →